Understanding Corporate VCs’ Investment Criteria

Corporate VCs often differ from traditional venture capitalists by prioritizing strategic value over purely financial returns. Michael Ryan, Vice President of Venture Capital & Business Development at Boston Scientific, emphasized the company’s active role in investing: “We’re one of the most active acquirers in the medtech industry, generally deploying somewhere north of $100 million a year into venture investments.” For more information visit here: https://tinyurl.com/5nbabbry

Why the Women’s Health Market Remains Underfunded

The women’s health market represents a massive and growing opportunity, yet it remains one of the most under-ventured sectors in healthcare. Despite women making up over half the population and accounting for the majority of healthcare spending decisions, investment in women’s health technologies and companies continues to lag. For more information visit https://www.slideshare.net/sli....deshow/why-the-women

Medtech and Healthtech in Africa: Opportunities and Investment

Africa’s healthcare landscape is undergoing a transformation driven by digital health, medtech, and biotech innovations. With a rapidly growing population, increasing urbanization, and rising demand for better healthcare solutions, medtech and healthtech in Africa present a significant investment opportunity. This blog is originally published here: https://www.lsiusasummit.com/n....ews/medtech-and-heal

Leadership Culture Change: A Case Study in Scaling Smarter

Organizational change is rarely easy—especially in high-growth medtech companies where rapid scaling can lead to misalignment, inefficiency, and decision-making bottlenecks. Without a clear framework, leadership culture change can feel like an uphill battle. At LSI USA ‘24, Todd Powell, President and CEO of RefleXion Medical, and Ed Muzio, President and CEO of Group Harmonics. This blog is originally published here: https://www.lsiusasummit.com/n....ews/leadership-cultu